Details of the Drug Formulation (DFM)
| General Information of DFM (ID: F20279) | |||||
|---|---|---|---|---|---|
| Name |
Sitagliptin 25 mg tablet
|
||||
| Company |
Avera McKennan Hospital; Merck Sharp & Dohme
|
||||
| Active Pharmaceutical Ingredient (API) | Sitagliptin |
API Info
 click to show the detail info of this API
|
|||
| Diabetes mellitus | ICD-11: 5A10 | Approved | |||
| Drug Inactive Ingredient (DIGs) | |||||
| DIG ID | DIG Info | DIG Name | DIG Functional Class | ||
| E0Q8ZK | DIG Info | Calcium hydrogenphosphate | Diluent | ||
| E03SQI | DIG Info | Carmellose sodium | Disintegrant | ||
| E09YYN | DIG Info | Eisenoxyd | Colorant | ||
| E0M0IE | DIG Info | Ferric hydroxide oxide yellow | Colorant | ||
| E01UTP | DIG Info | Magnesium stearate | lubricant | ||
| E0RS6F | DIG Info | Sodium stearyl fumarate | lubricant | ||
| E0QY1F | DIG Info | Talc | Anticaking agent ... | ||
| E05BSD | DIG Info | Titanium dioxide | Coating agent ... | ||
| Full List of Biological Targets of DIG (DBTs) Regulated by DIG(s) in This DFM | ||||||
|---|---|---|---|---|---|---|
| Oxidoreductase (ORase) | ||||||
| DBT Name: Albendazole monooxygenase (CYP3A4) | Click to Show/Hide | |||||
| Detailed Information |
DBT Info
click to show the detail info of this DBT
|
|||||
| Experiment (1) for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Interacting DIG | Magnesium stearate | |||||
| Biological Activity | Protein expression downregulation (tested by experiment) | [1] | ||||
| Tested Species | Homo sapiens (Human) | |||||
| UniProt ID | CP3A4_HUMAN | |||||
| Experiment (2) for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Interacting DIG | Calcium hydrogenphosphate | |||||
| Biological Activity | Protein expression downregulation (tested by experiment) | [1] | ||||
| Tested Species | Homo sapiens (Human) | |||||
| UniProt ID | CP3A4_HUMAN | |||||
| Experiment (3) for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Interacting DIG | Carmellose sodium | |||||
| Biological Activity | Protein expression upregulation (tested by experiment) | [1] | ||||
| Tested Species | Homo sapiens (Human) | |||||
| UniProt ID | CP3A4_HUMAN | |||||
| Experiment (4) for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Interacting DIG | Carmellose sodium | |||||
| Biological Activity | Protein expression upregulation (tested by experiment) | [1] | ||||
| Tested Species | Homo sapiens (Human) | |||||
| UniProt ID | CP3A4_HUMAN | |||||
| Cell line (CELL) | ||||||
| DBT Name: Leukemia K562 cells (K562) | Click to Show/Hide | |||||
| Detailed Information |
DBT Info
click to show the detail info of this DBT
|
|||||
| Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Interacting DIG | Sodium stearyl fumarate | |||||
| Biological Activity | IC50 = 20.2 ug.mL-1 (estimated based on the structural similarity with CHEMBL3126829 ) | [2] | ||||
| Structural Similarity | Tanimoto coefficient = 0.75 | |||||
| Tested Species | Homo sapiens (Human) | |||||
| Cellosaurus ID | CVCL_0004 | |||||
| DBT Name: Breast cancer MCF7 cells (MCF7) | Click to Show/Hide | |||||
| Detailed Information |
DBT Info
click to show the detail info of this DBT
|
|||||
| Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Interacting DIG | Sodium stearyl fumarate | |||||
| Biological Activity | IC50 = 60 ug.mL-1 (estimated based on the structural similarity with CHEMBL3126829 ) | [2] | ||||
| Structural Similarity | Tanimoto coefficient = 0.75 | |||||
| Tested Species | Homo sapiens (Human) | |||||
| Cellosaurus ID | CVCL_0031 | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.